市場調查報告書
商品編碼
1530769
2030 年益生菌市場預測:按產品類型、微生物類型、形式、分銷管道、應用、最終用戶和地區進行的全球分析Probiotics Market Forecasts to 2030 - Global Analysis By Product Type (Dietary Supplements, Functional Foods, Animal Feed and Other Product Types), Microorganism Type, Form, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球益生菌市場規模為 712 億美元,預計在預測期內將以 10.2% 的複合年成長率成長,到 2030 年達到 1,275 億美元。
益生菌是活的微生物,通常是細菌或酵母菌。透過促進有益細菌的生長並抑制有害細菌的生長,有助於維持腸道菌叢平衡。益生菌通常存在於發酵食品和膳食食品中,例如優格和Kefir。食用益生菌具有多種健康益處,包括改善消化、增強免疫功能和預防某些胃腸道疾病。
根據世界衛生組織(WHO)2022年報告,肥胖是歐洲多種非傳染性疾病(NCD)的主要危險因子之一,超過60%的成年人、29%的男孩和27%的女孩肥胖。
消費者腸道健康意識不斷增強
消費者對腸道健康意識的提升是市場的主要驅動力。隨著人們對平衡腸道菌叢的好處越來越了解,對益生菌補充品和食品的需求也在增加。人們對消化器官系統健康、免疫力和整體健康日益成長的興趣推動了這一趨勢。注重健康的消費者需要具有經過驗證的功效的產品,從而推動創新並擴大市場產品範圍。自然和預防性保健的趨勢進一步加速了益生菌在不同人群中的採用。
缺乏標準化
由於缺乏標準化,市場面臨重大挑戰。這個問題源自於益生菌法規和定義的地區差異,導致品質和功效不一致。由於缺乏有關菌株、劑量和健康聲明的標準化指南,導致消費者和醫療保健專業人員感到困惑。此外,呈現方法的多樣性進一步使市場複雜化,並阻礙消費者做出明智選擇的能力。
益生菌增強免疫力
由於消費者越來越意識到腸道環境對免疫功能的影響,該市場正在不斷成長。這些益生菌包括乳酸桿菌和雙叉桿菌等菌株,其配方旨在透過促進腸道菌叢的健康平衡來支持和增強免疫系統。這種平衡對於有效的免疫反應至關重要,並且可以降低感染疾病的頻率和嚴重程度。對預防性健康措施的日益重視增加了對這些專門益生菌產品的需求。
穩定性和保存期限挑戰
由於溫度變化、濕度和光照等因素,益生菌在長期維持其效力和活力方面經常面臨挑戰。這些條件會導致活微生物數量減少。有效的配方和包裝對於延長保存期限和確保產品功效至關重要。封裝和保存技術的創新旨在應對這些挑戰並提高產品穩定性。因此,穩定性和保存期限問題在市場上很重要。
COVID-19 大流行對市場產生了重大影響,促使消費者提高了對腸道健康和免疫力的認知。在大流行期間,隨著人們尋求增強免疫系統和改善整體健康狀況,對益生菌的需求顯著增加。儘管供應鏈中斷和製造延誤帶來了挑戰,但人們對健康和保健的興趣日益濃厚,加速了市場成長。大流行後,預防性健康措施的趨勢繼續推動益生菌市場的擴張。
機能性食品產業預計將在預測期內成為最大的產業。
由於消費者對腸道健康和保健的意識不斷增強,機能性食品預計將在預測期內獲得最高的市場佔有率。益生菌市場上的機能性食品富含活的有益細菌,可促進腸道健康和整體健康。這些產品,包括優格、Kefir和營養食品,除了基本營養之外還提供特定的健康益處。它還促進消化,支持免疫功能,並幫助控制大腸激躁症等疾病。
免疫健康領域預計在預測期內複合年成長率最高
免疫健康領域預計在預測期內複合年成長率最高。乳酸菌等益生菌菌株被廣泛用於增強腸道健康,這對於強大的免疫系統至關重要。這些益生菌有助於維持腸道菌叢平衡,進而影響您的整體免疫力。消費者預防保健意識的提高和胃腸道疾病發病率的增加正在推動對支持免疫功能的益生菌的需求,反映了市場的關鍵成長領域。
由於消費者對腸道健康益處的認知不斷提高以及對機能性食品和補充品的需求不斷增加,預計北美將在預測期內佔據最大的市場佔有率。該市場的特點是產品種類繁多,包括營養食品、乳製品和機能飲料。益生菌菌株和配方的進步進一步支持市場擴張。該地區的主要企業正專注於創新和戰略合作夥伴關係,以加強其產品供應並佔領更大的市場佔有率。
由於益生菌在預防醫學中的應用不斷增加,預計亞太地區在預測期內將維持最高的複合年成長率。隨著人口老化,對健康維護和疾病預防的需求增加,導致益生菌的消費量增加。主要企業增加研發投資將提高產品的有效性和採用率。日本、中國和印度等政府正在透過有利的法規和指導方針來支持益生菌產業。
According to Stratistics MRC, the Global Probiotics Market is accounted for $71.2 billion in 2024 and is expected to reach $127.5 billion by 2030 growing at a CAGR of 10.2% during the forecast period. Probiotics are live microorganisms, typically bacteria or yeast, that provides health benefits when consumed in adequate amounts. They contribute to the maintenance of a balanced gut microbiota by enhancing the growth of beneficial bacteria and inhibiting harmful ones. Probiotics are often found in fermented foods like yogurt and kefir, or as dietary supplements. Their consumption is associated with various health benefits, including improved digestion, enhanced immune function, and prevention of certain gastrointestinal disorders.
According to the World Health Organization (WHO) 2022 report, one of the major risk factors for several noncommunicable diseases (NCDs) in Europe is obesity, and over 60% of adults and 29% of boys, and 27% of girls who are children are overweight.
Rising consumer awareness of gut health
Rising consumer awareness of gut health is significantly driving the market. As people become more informed about the benefits of a balanced gut microbiome, demand for probiotic supplements and foods is increasing. This trend is fueled by growing interest in digestive health, immunity, and overall wellness. Health-conscious consumers are seeking products with proven benefits, propelling innovations and expanding product offerings in the market. The emphasis on natural and preventive healthcare further accelerates the adoption of probiotics across various demographics.
Lack of standardization
The market faces a significant challenge due to the lack of standardization. This issue arises from varying regulations and definitions of probiotics across different regions, leading to inconsistent quality and efficacy. The absence of standardized guidelines for strains, dosages, and health claims creates confusion among consumers and healthcare professionals. Moreover, the diversity in labeling practices further complicates the market, hindering the ability of consumers to make informed choices.
Probiotics for Immunity Enhancement
The market is experiencing growth due to increasing consumer awareness of gut health's impact on immune function. These probiotics, including strains such as Lactobacillus and Bifidobacterium, are formulated to support and strengthen the immune system by promoting a healthy balance of gut microbiota. This balance is crucial for an effective immune response, potentially reducing the frequency and severity of infections. The growing emphasis on preventative health measures is driving demand for these specialized probiotic products.
Stability and shelf-life challenges
Probiotics often face difficulties in maintaining potency and viability over time due to factors such as temperature fluctuations, humidity, and exposure to light. These conditions can lead to a decline in the number of viable microorganisms. Effective formulation and packaging are crucial to prolong shelf life and ensure product efficacy. Innovations in encapsulation and storage technology aim to address these challenges and enhance product stability. Thus, in the market, stability and shelf-life challenges are significant.
The COVID-19 pandemic significantly impacted the market, driving increased consumer awareness of gut health and immunity. During the pandemic, there was a notable surge in demand for probiotics as people sought to boost their immune systems and overall wellness. Disruptions in supply chains and manufacturing delays posed challenges, yet the heightened focus on health and wellness accelerated market growth. Post-pandemic, the trend towards preventive health measures continues to fuel the probiotics market's expansion.
The functional foods segment is expected to be the largest during the forecast period
The functional foods is expected to be the largest during the forecast period due to growing consumer awareness about gut health and wellness. Functional foods in the probiotics market are fortified with live beneficial bacteria that promote gut health and overall wellness. These products, including yogurt, kefir, and dietary supplements, offers specific health benefits beyond basic nutrition. They enhance digestion, support immune function, and can help manage conditions like irritable bowel syndrome.
The immune health segment is expected to have the highest CAGR during the forecast period
The immune health segment is expected to have the highest CAGR during the forecast period. Probiotic strains such as Lactobacillus are widely used to bolster gut health, which is crucial for a robust immune system. These probiotics help maintain a balanced gut microbiome, which can influence systemic immunity. Rising consumer awareness about preventive healthcare and increasing incidences of gastrointestinal disorders are driving the demand for probiotics that support immune function, reflecting a significant growth area in the market.
North America is projected to hold the largest market share during the forecast period driven by rising consumer awareness of gut health benefits and increased demand for functional foods and supplements. The market is characterized by a diverse range of products, including dietary supplements, dairy products, and functional beverages. Advances in probiotic strains and formulations are further fueling market expansion. Key players in the region are focusing on innovation and strategic partnerships to enhance product offerings and capture a larger market share.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to increasing use of probiotics in preventive healthcare. An aging demographic is driving the need for health maintenance and disease prevention, leading to increased probiotic consumption. Rising investments in research and development by key players enhance product efficacy and reach. Governments in countries like Japan, China, and India are supporting the probiotics sector with favorable regulations and guidelines.
Key players in the market
Some of the key players in Probiotics market include Danone S.A., Nestle S.A., Yakult Honsha Co., Ltd., Archer Daniels Midland Company, Procter & Gamble Co., Kerry Group plc, General Mills, Inc., Lifeway Foods, Inc., BASF SE, Royal DSM N.V., PepsiCo, Inc., Groupe Danone, Symrise AG, Wacker Chemie AG, Merck KGaA and AB Biotics SA.
In February 2024, AB Biotics SA expands its presence in Asia, partnering with Wonderlab for their globally marketed product, AB-LIFE . The collaboration introduces Shape100 , a probiotic blend focusing on cardiometabolic health, to the Chinese market. This strategic move aims to address cholesterol-related concerns through evidence-based solutions.
In November 2023, Nestle launched N3 milk, a breakthrough in nutritional innovation. Incorporating prebiotic fibers and reduced lactose, it enriches gut health and boasts over 15% fewer calories. Tailored for diverse dietary needs, N3 supports bone health, muscle growth, and immunity.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.